{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-005288","form_type":"8-K","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.387927+00:00","generated_at":"2026-05-17T15:09:51.249757+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Harvard Bioscience gets covenant waiver, interest rate jumps to SOFR+700bps; going concern doubt","bullets":["Waived defaults for failing Q2 2025 financial covenants; no covenant test for Q3 2025.","Interest rate increased to SOFR+700bps (ABR+650bps); $0.4M fee (1% of debt) payable.","Must take steps toward refinancing by Dec 5, 2025 or face default; mandatory prepayment on refinancing/sale.","Minimum liquidity of $3M required; company warns of substantial doubt about going concern."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-005288","json":"https://secwatch.observer/filing/0001171843-25-005288.json","markdown":"https://secwatch.observer/filing/0001171843-25-005288.md","text":"https://secwatch.observer/filing/0001171843-25-005288.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325005288/0001171843-25-005288-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184325005288/f8k_080825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:09:51.249757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}